Clinical Trial Update: Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Pancrecarb MS-16 in cystic fibrosis with pancreatic insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Insufficiency

Drugs mentioned

• Pancrecarb MS-16 (Pancrecarb MS-16)

Snippet

Sponsor: Digestive Care, Inc. | Conditions: Cystic Fibrosis, Pancreatic Insufficiency | Phase 3 | Status: COMPLETED